Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00979602 · ClinicalTrials.gov registry record · Phase 3

Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older

A Phase 3 study of Influenza, sponsored by GlaxoSmithKline.

Completed
Registry status
Phase 3
Development phase
4,048
Enrollment target
20
Study locations

NCT00979602 is a Phase 3 study of Influenza that has completed, run by GlaxoSmithKline. The registered enrollment target is 4,048 participants, below the 36,778-participant average among 156 other Influenza trials with a reported enrollment target (89% lower). The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00979602, a Phase 3 study of Influenza, has completed, sponsored by GlaxoSmithKline.

COMPLETED
Registry status
Phase 3
Development phase
4,048 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to characterize the safety, immunogenicity, and relative efficacy of the H1N1 (swine) flu vaccines GSK2340273A and GSK2340274A in adults 18 years of age or older.

Conditions Studied

Influenza

Interventions

  • BIOLOGICAL GSK2340274A
  • BIOLOGICAL GSK2340273A

Study Locations (20)

Florida

  • GSK Investigational Site - Clearwater
  • GSK Investigational Site - DeLand
  • GSK Investigational Site - Delray Beach
  • GSK Investigational Site - Jacksonville

Arizona

  • GSK Investigational Site - Mesa
  • GSK Investigational Site - Phoenix
  • GSK Investigational Site - Phoenix

Maryland

  • GSK Investigational Site - Columbia
  • GSK Investigational Site - Rockville

New York

  • GSK Investigational Site - Binghamton
  • GSK Investigational Site - Camillus

California

  • GSK Investigational Site - Los Angeles

Illinois

  • GSK Investigational Site - Chicago

Kansas

  • GSK Investigational Site - Wichita

Kentucky

  • GSK Investigational Site - Lexington

Trial Details

FieldValue
Enrollment Target 4,048 participants
Start Date 2009-11-09
Est. Completion 2011-02-01
Phase Phase 3

Sponsor

GlaxoSmithKline

1,345 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00979602

The ClinicalTrials.gov registry entry for NCT00979602 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 4,048 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 36,778-participant average among 156 other Influenza trials with a reported enrollment target (89% lower). The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Influenza appearing as the primary indexed condition, and to 2 interventions - of which GSK2340274A is the first listed.

NCT00979602 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Florida, Arizona, Maryland.

Frequently Asked Questions

What is clinical trial NCT00979602 about?

NCT00979602 is a clinical study titled "Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older". The purpose of this study is to characterize the safety, immunogenicity, and relative efficacy of the H1N1 (swine) flu vaccines GSK2340273A and GSK2340274A in adults 18 years of age or older.

What is the current status of trial NCT00979602?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 4,048 participants. The study started on 2009-11-09. Estimated completion is 2011-02-01.

What conditions does trial NCT00979602 study?

This clinical trial studies the following conditions: Influenza.

What interventions are being tested in trial NCT00979602?

The interventions under investigation include: GSK2340274A (BIOLOGICAL), GSK2340273A (BIOLOGICAL).

Who is sponsoring clinical trial NCT00979602?

This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00979602 being conducted?

This trial has 20 study locations across Arizona, California, Florida, Illinois, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Influenza

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Influenza

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.